Clinical Trials Browser

Completed × rovalpituzumab tesirine × Clear all

NCT03000257 2022-04-14

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Phase 1 Completed

BreastDermatologicGastrointestinalGynecologicHead & NeckOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Carcinoma, Merkel Cell, Cholangiocarcinoma, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03086239 2021-08-03

A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung Cancer

Phase 1 Completed

Neoplasms, Small Cell Lung Carcinoma

NCT02674568 2021-07-30

TRINITY

Phase 2 Completed

342 enrolled 18 charts

Recurrence, Small Cell Lung Carcinoma

NCT03061812 2021-02-23

TAHOE

Phase 3 Completed

444 enrolled 16 charts

Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT03543358 2021-01-05

A Long-Term Study of Rovalpituzumab Tesirine

Phase 2 Completed

3 enrolled 6 charts

Neoplasms

NCT02874664 2018-09-24

A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer

Phase 1 Completed

Small Cell Lung Carcinoma

NCT01901653 2018-08-09

Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer

Phase 1/2 Completed

82 enrolled 28 charts

Small Cell Lung Carcinoma